The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index, and 1 are not checked yet.
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Open accessAbstract
GABAA (γ-aminobutyric acid, type A) receptors are a family of ligand-gated ion channels that are essential for the regulation of central nervous system function. Benzodiazepines — which non-selectively target GABAA receptors containing the α1, α2, α3 or α5 subunits — have been in clinical use for decades and are still among the most widely prescribed drugs for the treatment of insomnia and anxiety disorders. However, their use is limited by side effects and the risk of drug dependence. In the past decade, the identification of separable key functions of GABAA receptor subtypes suggests that receptor subtype-selective compounds could overcome the limitations of classical benzodiazepines; furthermore, they might be valuable for novel indications such as chronic pain, depression, schizophrenia, cognitive enhancement and stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since benzodiazepines enhance the effect of GABA on GABAA receptors 72 ,”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 1×
“In post-mortem brain from patients with schizophrenia, there is an upregulation of the α2 subunit in the axon initial segments of these pyramidal neuron”
BackgroundBenzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,709 · cited 1×
“Benzodiazepines have been shown to bind to specific sites in the central nervous syste”
BackgroundNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Although there is tremendous interest in developing antidepressant agents that utilize different mechanisms of action, the development of such agents has not yet been successfu”
BackgroundBenzodiazepine receptors in rat brain
Squires, R. F., & Bræstrup, C. (1977) · Nature · doi:10.1038/266732a0 · Cited by 1,453
GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., & Sperk, G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00442-5 · Cited by 1,344
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Self-citationOlsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · cited 1×
“, activates tonic firing of dopaminergic neurons in the midbrain; this circuit involves glutamatergic neurons in the hippocampus, GABAergic neurons in the nucleus accumbens and GABAergic neurons in the ventral pallidu”
Background
Cited by
Sorted by citations
Items 701–745 of 745
Plasticité GABAergique et épilepsie : focus sur le proBDNF
Riffault, B. (2016) · theses.fr (ABES) · doi:10.70675/aebe024bzc909z4a8azaf3az2554d9189e99
Neuromodulation in the Olfactory Bulb
Smith, R. E. (2015) · theses.fr (ABES) · doi:10.70675/a431d14fz588cz4bdcz8e0ezd4f43eba4e60
Forcing alpha-cell-mediated beta-cell regeneration
Ben-Othman, N. (2015) · theses.fr (ABES) · doi:10.70675/376c5af0zd161z4a1ez92aez1b3746176067
“There are 19 known GABAAR subunits: α1-6, β1-3, γ13, δ, ε, θ, π and ρ1-3 (Luddens et al., 1995; Olsen and Tobin, 1990; Rudolph and Knoflach, 2011).”
BackgroundBlood-based biomarkers for traumatic brain injury
Rezzag, A. (2021) · theses.fr (ABES) · doi:10.70675/330bcff7z665fz4924z9a1bz947c6b1f9484
Metabolic Roles of Acyl Coenzyme A-Binding Protein (ACBP)/Diazepam Binding Inhibitor (DBI)
Joseph, A. (2021) · theses.fr (ABES) · doi:10.70675/b045685ezd444z4b46zb0f9z0e726ceac466
Park, I., Kim, S.-O., Park, Y., et al. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103046
Zhou, Y.-K., Wu, W., Zhang, Y., Peng, Y., Jiang, W.-C., Zhang, X.-J., Ju, F., & Xie, A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1793528 · Cited by 2
“Remimazolam demonstrates aÿnity for α 1, α 2-, α 3-, and α 5-containing receptor subtypes without demonstrating clear selectivity among them (3, 21).”
Islam, M. R., Sheikh, S., Chowdhury, R., Bhuia, M. S., Islam, M. R., Araújo, I. M., Domiciano, C. B., Coutinho, H. D. M., & Saifuzzaman, M. (2026) · Iranian Journal of Science · doi:10.1007/s40995-026-01990-7
“After reviewing the literature, we determined which GABA A macromolecules mediate sedation and obtained the GABA A receptor’s 3D structure, which includes the α 1 and β 2 sub-units (PDB ID: 6X3X), from the RCSB protein data repository (Reynolds et al. 2003 , Rudolph and Knoflach 2011).”
Mixcoha, E., Zamora, A. F., Hernández-Miramontes, R., Hernández-Calderón, J. A., & Martiñón, S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1813618
“Positive allosteric modulators (PAMs), especially benzodiaze-pines, have been central to anxiety treatment for decades because they potentiate GABAergic inhibition and usually produce rapid symptom relief (Rudolph and Mohler, 2004; Rudolph and Knoflach, 2011).”
Hyperacusis-inducing drug candidates
Salvi, R., Wang, T.-C., & Eddins, A. C. (2026) · Hearing Research · doi:10.1016/j.heares.2026.109673
Katsuki, F., Bauer, M. C., Vaughn, M. J., Lombardi, V., Brown, R. E., Haas, J. S., Basheer, R., & Uygun, D. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.728431
“The percentage of time spent in wakefulness, NREM sleep, and REM sleep, or bout profiles were not different between the two groups.”
Akhter, S., Khatun, M., Rouf, R., Ahammed, S., Siddique, A. B., Bhuia, M. S., Alfaifi, M., Altemani, F., Altemani, A. H., Hoque, M., et al. (2026) · ChemistrySelect · doi:10.1002/slct.202505933
Iannone, L. F., Romozzi, M., Pani, L., & Tascedda, F. (2026) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2026.2687030 · Cited by 1
“By focusing on α2/α3/α5 subunits, darigabat represents one of the first clinically advanced attempt to achieve functional specificity within this receptor family [21,36].”
Diazepam selectively biases approach during threat–reward conflict while sparing reactive avoidance
Enciso-Pablo, Ó., Sierra-Ramírez, F., & Sotres-Bayón, F. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07105-9
Liu, J., Zhu, W., Zhang, Z., Zhao, Q., & Wang, Y. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05648-4 · Cited by 1
“Research utilizing genetically modified knock-in (KI) mouse models demonstrated that binding at this site is essential for BZD-mediated modulation (Wieland et al. 1992; Benson et al. 1998; Atack 2010; Rudolph and Knoflach 2011).”
Ziablitsev, S. V., Aleksandrenko, N. O., Yevstifeiev, D. I., Babenko, M., & Likhodiievskyi, V. V. (2026) · Research Square · doi:10.21203/rs.3.rs-10044242/v1
Yang, X., Chen, C.-Y., Wang, Y.-F., & Zhang, Y. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111826
Nomoto, K., Ohtani, Y., Yatomi, T., Yonezawa, K., Tomiyama, S., Nagai, N., Kusudo, K., Honda, S., Moriyama, S., Nakajima, S., et al. (2026) · Pharmacopsychiatry · doi:10.1055/a-2894-5681
Lee, M., Chen, C., Kou, H., et al. (2026) · Analytical Methods · doi:10.1039/d6ay00839a
Moraru, M. V., Coman, O. A., Zugravu, A., Stoleru, S., Ghiță, C. I. V., Costescu, M., Poenaru, E., Dragomir, A.-F., Barbu, A. C., Luncă, D.-C., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19081282
“This pharmacological selectivity is thought to underlie their predominantly sedative–hypnotic profile and their reduced impact on memory function compared to classical benzodiazepines [25,26].”
Gundim, V. A., da Silva, H. C., Costa, R. C. D. A., Nascimento, L. F. S., Jovita-Farias, C., Tiruveedhula, V. V. N. P. B., Mondal, P., Favoretto, C. A., Cook, J. M., Rowlett, J. K., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261473409
Loberamisal for Acute Ischemic Stroke
Li, S., Feng, B., He, D., Wang, X., Li, H., Xu, S., Gu, H., Xiao, X., Deng, D., Wang, X., et al. (2026) · JAMA · doi:10.1001/jama.2026.16557
Wang, W.-J. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1693222
Rossetti, M. F., Fernández, P., Canesini, G., Diaz, D. O., Stoker, C., & Ramos, J. G. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.108034
Ferreira, M. K. A., da Silva, A. W., Mendes, F. R. D. S., Marinho, E. S., da Fonseca, A. M., Marinho, M. M., Teixeira, I. M. M., Pinto, F. D. C. L., de Menezes, R. R. P. P. B., Gomes, A. F. D. C., et al. (2026) · Chemical Papers · doi:10.1007/s11696-026-05718-0
Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review
Naghinejad, M., Motallebi, F., Hasani, E., et al. (2026) · Health Science Reports · doi:10.1002/hsr2.73323
“Benzodiazepines are well‐characterized positive allosteric modulators of GABA A receptors, enhancing chloride influx to produce sedative and anxiolytic effects [40, 41].”
Latif, M., Ouahdi, Z., Chtita, S., et al. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147839
Besson, M., Matthey, A., Daali, Y., Ramsahye, A., Samer, C., Desmeules, J., & Curtin, F. (2026) · European Journal of Pain · doi:10.1002/ejp.70413
“However, all identified selective compounds failed early in clinical development (Rudolph and Knoflach 2011) because they all were only partial agonists at α-2 receptors and lost their selectivity at doses required for analgesia in humans (van Amerongen et al. 2019; Gurrell et al. 2018; Ralvenius…”
The Serenity Spectrum: Integrating Anxiolytic and Antidepressant Mechanisms for Stress relief
Harini., M. B., & Verma, P. (2026) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2026.00063
An acetylcholine-inhibited sleep-active hippocampal interneuron orchestrates memory consolidation
Feng, Y., Dai, Q., Fei, X., Yang, H., Jiang, T., Liu, Z., Ye, L., Lin, Z., Gao, S., Hu, R., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.031 · Cited by 1
BindingDB (2014) · UC San Diego · doi:10.7270/q22z1705
BindingDB (2020) · UC San Diego · doi:10.7270/q25x2cxw
BindingDB Entry 50007820: Design and Identification of a Novel, Functionally Subtype Selective GABA
BindingDB (2021) · UC San Diego · doi:10.7270/q2hq437d
BindingDB (2020) · UC San Diego · doi:10.7270/q2d79f10
Engel, M. (2014) · Research Online (University of Wollongong)
Metadata
- Authors
- Rudolph, U., & Knoflach, F.
- Affiliations
- Harvard University (US)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-07-29
- Volume
- 10
- Issue
- 9
- Pages
- 685-697
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3375401
- OpenAlex
- W2013775967
- Semantic Scholar
- bfb4fcd647899053b94eaf5edf1fe9e748076c6b
- Cited by
- 733
- References
- 111
- Citations by year
- 2026: 41 · 2025: 42 · 2024: 35 · 2023: 46 · 2022: 43 · 2021: 55 · 2020: 49 · 2019: 56 · 2018: 51 · 2017: 58 · 2016: 52 · 2015: 45 · 2014: 62 · 2013: 58 · 2012: 38
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH087829, R01MH080006, R03MH085149, MH087829, MH085149, MH080006)
- National Institute on Drug Abuse (DA027051, DA026578, R03DA026578, R03DA027051)
- National Institute of General Medical Sciences (R01GM086448, GM086448)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- GABAA receptor, benzodiazepines, GABAA receptor subtypes, ligand-gated ion channels, chronic pain, depression, schizophrenia, cognitive enhancement, stroke, drug addiction
- MeSH terms
- Analgesics, Animals, Anxiety Disorders, Benzodiazepines, Depressive Disorder, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Mutation, Receptors, GABA-A, Schizophrenia, Nootropic Agents, GABA Modulators, Substance-Related Disorders, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review